HEADER FLUORESCENT PROTEIN 07-FEB-07 2OTB TITLE CRYSTAL STRUCTURE OF A MONOMERIC CYAN FLUORESCENT PROTEIN IN THE TITLE 2 FLUORESCENT STATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: GFP-LIKE FLUORESCENT CHROMOPROTEIN CFP484; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CLAVULARIA SP.; SOURCE 3 ORGANISM_TAXID: 86521; SOURCE 4 GENE: CFP484; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: TOP10; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PBAD/HISB KEYWDS BETA CAN, FLUORESCENT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.N.HENDERSON,H.AI,R.E.CAMPBELL,S.J.REMINGTON REVDAT 7 15-NOV-23 2OTB 1 REMARK REVDAT 6 30-AUG-23 2OTB 1 SEQADV LINK REVDAT 5 18-OCT-17 2OTB 1 REMARK REVDAT 4 22-FEB-12 2OTB 1 SEQRES SEQADV HET HETATM REVDAT 4 2 1 HETNAM LINK REMARK MODRES REVDAT 4 3 1 VERSN REVDAT 3 24-FEB-09 2OTB 1 VERSN REVDAT 2 08-MAY-07 2OTB 1 JRNL REVDAT 1 03-APR-07 2OTB 0 JRNL AUTH J.N.HENDERSON,H.W.AI,R.E.CAMPBELL,S.J.REMINGTON JRNL TITL STRUCTURAL BASIS FOR REVERSIBLE PHOTOBLEACHING OF A GREEN JRNL TITL 2 FLUORESCENT PROTEIN HOMOLOGUE. JRNL REF PROC.NATL.ACAD.SCI.USA V. 104 6672 2007 JRNL REFN ISSN 0027-8424 JRNL PMID 17420458 JRNL DOI 10.1073/PNAS.0700059104 REMARK 2 REMARK 2 RESOLUTION. 1.79 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.79 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 40128 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 4039 REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 40185 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3370 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 410 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.009 ; 1.000 ; 3517 REMARK 3 BOND ANGLES (DEGREES) : 1.344 ; 1.000 ; 4770 REMARK 3 TORSION ANGLES (DEGREES) : 17.920; 0.000 ; 2036 REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : 0.008 ; 2.000 ; 77 REMARK 3 GENERAL PLANES (A) : 0.014 ; 5.000 ; 526 REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : 3.089 ; 1.000 ; 3465 REMARK 3 NON-BONDED CONTACTS (A) : 0.451 ; 10.000; 26 REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.80 REMARK 3 BSOL : 150.0 REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : ENGH & HUBER REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : ISOTROPIC REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2OTB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-FEB-07. REMARK 100 THE DEPOSITION ID IS D_1000041559. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-DEC-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : DOUBLE-CRYSTAL, SI(111) LIQUID REMARK 200 N2 COOLED REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40185 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.790 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : 0.07300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.79 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.9 REMARK 200 DATA REDUNDANCY IN SHELL : 6.60 REMARK 200 R MERGE FOR SHELL (I) : 0.17600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 21.10 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR 2.5 REMARK 200 STARTING MODEL: PDB ENTRY 1ZUX, CHAIN A REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.88 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 31% PEG 3400, 0.2 M LITHIUM SULFATE, REMARK 280 0.1 M SODIUM ACETATE, 2.9 MM 1-S-NONYL-BETA-D-THIOGLUCOSIDE, PH REMARK 280 4.8, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.50800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.69100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.86800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.69100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.50800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.86800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A MONOMER. THERE ARE TWO REMARK 300 MONOMERS IN THE ASYMMETRIC UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 9 NZ REMARK 470 LYS A 13 NZ REMARK 470 LYS A 15 CD CE NZ REMARK 470 LYS A 17 NZ REMARK 470 GLU A 19 CD OE1 OE2 REMARK 470 GLU A 32 OE1 OE2 REMARK 470 GLU A 34 CD OE1 OE2 REMARK 470 LYS A 36 CE NZ REMARK 470 GLU A 50 OE1 OE2 REMARK 470 LYS A 74 NZ REMARK 470 ASP A 77 CG OD1 OD2 REMARK 470 LYS A 102 CG CD CE NZ REMARK 470 LYS A 106 NZ REMARK 470 LYS A 108 CD CE NZ REMARK 470 ILE A 119 CD1 REMARK 470 GLU A 127 CG CD OE1 OE2 REMARK 470 ASN A 132 OD1 ND2 REMARK 470 LYS A 138 CE NZ REMARK 470 LYS A 139 CE NZ REMARK 470 LYS A 162 CE NZ REMARK 470 LYS A 164 NZ REMARK 470 GLU A 168 CD OE1 OE2 REMARK 470 ARG A 174 NE CZ NH1 NH2 REMARK 470 LYS A 188 CE NZ REMARK 470 LYS A 206 CD CE NZ REMARK 470 ARG A 220 CD NE CZ NH1 NH2 REMARK 470 TYR A 221 CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLY B 6 N CA REMARK 470 LYS B 9 CG CD CE NZ REMARK 470 ASP B 11 OD1 OD2 REMARK 470 LYS B 15 CD CE NZ REMARK 470 LYS B 17 CE NZ REMARK 470 GLU B 19 CD OE1 OE2 REMARK 470 GLU B 32 CD OE1 OE2 REMARK 470 GLU B 34 CD OE1 OE2 REMARK 470 LYS B 36 CD CE NZ REMARK 470 LYS B 74 CE NZ REMARK 470 GLN B 85 CG CD OE1 NE2 REMARK 470 ASP B 101 CG OD1 OD2 REMARK 470 LYS B 102 CG CD CE NZ REMARK 470 LYS B 106 CD CE NZ REMARK 470 LYS B 108 CE NZ REMARK 470 GLU B 121 CD OE1 OE2 REMARK 470 LYS B 125 NZ REMARK 470 LYS B 138 NZ REMARK 470 LYS B 139 CE NZ REMARK 470 LYS B 162 CD CE NZ REMARK 470 ARG B 174 NE CZ NH1 NH2 REMARK 470 ARG B 198 CZ NH1 NH2 REMARK 470 LYS B 206 CG CD CE NZ REMARK 470 LYS B 210 NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 102 -16.73 84.24 REMARK 500 GLU A 115 -128.87 51.76 REMARK 500 ASP A 116 34.20 -92.94 REMARK 500 ASN A 132 50.71 -112.57 REMARK 500 ARG B 70 1.16 -60.79 REMARK 500 ASP B 77 14.65 55.97 REMARK 500 ASP B 101 43.06 -95.73 REMARK 500 LYS B 102 -11.31 76.92 REMARK 500 GLU B 115 -132.78 51.29 REMARK 500 ASP B 116 34.95 -89.04 REMARK 500 LYS B 142 173.00 179.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2OTE RELATED DB: PDB DBREF 2OTB A 6 221 UNP Q9U6Y3 GFPL_CLASP 44 259 DBREF 2OTB B 6 221 UNP Q9U6Y3 GFPL_CLASP 44 259 SEQADV 2OTB ASN A 42 UNP Q9U6Y3 HIS 80 ENGINEERED MUTATION SEQADV 2OTB ILE A 44 UNP Q9U6Y3 LEU 82 ENGINEERED MUTATION SEQADV 2OTB THR A 62 UNP Q9U6Y3 SER 100 ENGINEERED MUTATION SEQADV 2OTB PIA A 66 UNP Q9U6Y3 GLN 104 CHROMOPHORE SEQADV 2OTB PIA A 66 UNP Q9U6Y3 TYR 105 CHROMOPHORE SEQADV 2OTB PIA A 66 UNP Q9U6Y3 GLY 106 CHROMOPHORE SEQADV 2OTB PHE A 72 UNP Q9U6Y3 LEU 110 ENGINEERED MUTATION SEQADV 2OTB PRO A 80 UNP Q9U6Y3 ALA 118 ENGINEERED MUTATION SEQADV 2OTB ASN A 81 UNP Q9U6Y3 ASP 119 ENGINEERED MUTATION SEQADV 2OTB HIS A 123 UNP Q9U6Y3 ARG 161 ENGINEERED MUTATION SEQADV 2OTB LEU A 124 UNP Q9U6Y3 PHE 162 ENGINEERED MUTATION SEQADV 2OTB LYS A 125 UNP Q9U6Y3 ASP 163 ENGINEERED MUTATION SEQADV 2OTB GLU A 127 UNP Q9U6Y3 MET 165 ENGINEERED MUTATION SEQADV 2OTB LEU A 150 UNP Q9U6Y3 MET 188 ENGINEERED MUTATION SEQADV 2OTB LYS A 162 UNP Q9U6Y3 SER 200 ENGINEERED MUTATION SEQADV 2OTB LYS A 164 UNP Q9U6Y3 SER 202 ENGINEERED MUTATION SEQADV 2OTB HIS A 173 UNP Q9U6Y3 TYR 211 ENGINEERED MUTATION SEQADV 2OTB VAL A 175 UNP Q9U6Y3 CYS 213 ENGINEERED MUTATION SEQADV 2OTB THR A 179 UNP Q9U6Y3 SER 217 ENGINEERED MUTATION SEQADV 2OTB ARG A 182 UNP Q9U6Y3 LYS 220 ENGINEERED MUTATION SEQADV 2OTB ALA A 186 UNP Q9U6Y3 VAL 224 ENGINEERED MUTATION SEQADV 2OTB VAL A 213 UNP Q9U6Y3 LEU 251 ENGINEERED MUTATION SEQADV 2OTB SER A 216 UNP Q9U6Y3 ASN 254 ENGINEERED MUTATION SEQADV 2OTB ASN B 42 UNP Q9U6Y3 HIS 80 ENGINEERED MUTATION SEQADV 2OTB ILE B 44 UNP Q9U6Y3 LEU 82 ENGINEERED MUTATION SEQADV 2OTB THR B 62 UNP Q9U6Y3 SER 100 ENGINEERED MUTATION SEQADV 2OTB PIA B 66 UNP Q9U6Y3 GLN 104 CHROMOPHORE SEQADV 2OTB PIA B 66 UNP Q9U6Y3 TYR 105 CHROMOPHORE SEQADV 2OTB PIA B 66 UNP Q9U6Y3 GLY 106 CHROMOPHORE SEQADV 2OTB PHE B 72 UNP Q9U6Y3 LEU 110 ENGINEERED MUTATION SEQADV 2OTB PRO B 80 UNP Q9U6Y3 ALA 118 ENGINEERED MUTATION SEQADV 2OTB ASN B 81 UNP Q9U6Y3 ASP 119 ENGINEERED MUTATION SEQADV 2OTB HIS B 123 UNP Q9U6Y3 ARG 161 ENGINEERED MUTATION SEQADV 2OTB LEU B 124 UNP Q9U6Y3 PHE 162 ENGINEERED MUTATION SEQADV 2OTB LYS B 125 UNP Q9U6Y3 ASP 163 ENGINEERED MUTATION SEQADV 2OTB GLU B 127 UNP Q9U6Y3 MET 165 ENGINEERED MUTATION SEQADV 2OTB LEU B 150 UNP Q9U6Y3 MET 188 ENGINEERED MUTATION SEQADV 2OTB LYS B 162 UNP Q9U6Y3 SER 200 ENGINEERED MUTATION SEQADV 2OTB LYS B 164 UNP Q9U6Y3 SER 202 ENGINEERED MUTATION SEQADV 2OTB HIS B 173 UNP Q9U6Y3 TYR 211 ENGINEERED MUTATION SEQADV 2OTB VAL B 175 UNP Q9U6Y3 CYS 213 ENGINEERED MUTATION SEQADV 2OTB THR B 179 UNP Q9U6Y3 SER 217 ENGINEERED MUTATION SEQADV 2OTB ARG B 182 UNP Q9U6Y3 LYS 220 ENGINEERED MUTATION SEQADV 2OTB ALA B 186 UNP Q9U6Y3 VAL 224 ENGINEERED MUTATION SEQADV 2OTB VAL B 213 UNP Q9U6Y3 LEU 251 ENGINEERED MUTATION SEQADV 2OTB SER B 216 UNP Q9U6Y3 ASN 254 ENGINEERED MUTATION SEQRES 1 A 214 GLY VAL ILE LYS PRO ASP MET LYS ILE LYS LEU LYS MET SEQRES 2 A 214 GLU GLY ASN VAL ASN GLY HIS ALA PHE VAL ILE GLU GLY SEQRES 3 A 214 GLU GLY GLU GLY LYS PRO TYR ASP GLY THR ASN THR ILE SEQRES 4 A 214 ASN LEU GLU VAL LYS GLU GLY ALA PRO LEU PRO PHE SER SEQRES 5 A 214 TYR ASP ILE LEU THR ASN ALA PHE PIA ASN ARG ALA PHE SEQRES 6 A 214 THR LYS TYR PRO ASP ASP ILE PRO ASN TYR PHE LYS GLN SEQRES 7 A 214 SER PHE PRO GLU GLY TYR SER TRP GLU ARG THR MET THR SEQRES 8 A 214 PHE GLU ASP LYS GLY ILE VAL LYS VAL LYS SER ASP ILE SEQRES 9 A 214 SER MET GLU GLU ASP SER PHE ILE TYR GLU ILE HIS LEU SEQRES 10 A 214 LYS GLY GLU ASN PHE PRO PRO ASN GLY PRO VAL MET GLN SEQRES 11 A 214 LYS LYS THR LEU LYS TRP GLU PRO SER THR GLU ILE LEU SEQRES 12 A 214 TYR VAL ARG ASP GLY VAL LEU VAL GLY ASP ILE LYS HIS SEQRES 13 A 214 LYS LEU LEU LEU GLU GLY GLY GLY HIS HIS ARG VAL ASP SEQRES 14 A 214 PHE LYS THR ILE TYR ARG ALA LYS LYS ALA VAL LYS LEU SEQRES 15 A 214 PRO ASP TYR HIS PHE VAL ASP HIS ARG ILE GLU ILE LEU SEQRES 16 A 214 ASN HIS ASP LYS ASP TYR ASN LYS VAL THR VAL TYR GLU SEQRES 17 A 214 SER ALA VAL ALA ARG TYR SEQRES 1 B 214 GLY VAL ILE LYS PRO ASP MET LYS ILE LYS LEU LYS MET SEQRES 2 B 214 GLU GLY ASN VAL ASN GLY HIS ALA PHE VAL ILE GLU GLY SEQRES 3 B 214 GLU GLY GLU GLY LYS PRO TYR ASP GLY THR ASN THR ILE SEQRES 4 B 214 ASN LEU GLU VAL LYS GLU GLY ALA PRO LEU PRO PHE SER SEQRES 5 B 214 TYR ASP ILE LEU THR ASN ALA PHE PIA ASN ARG ALA PHE SEQRES 6 B 214 THR LYS TYR PRO ASP ASP ILE PRO ASN TYR PHE LYS GLN SEQRES 7 B 214 SER PHE PRO GLU GLY TYR SER TRP GLU ARG THR MET THR SEQRES 8 B 214 PHE GLU ASP LYS GLY ILE VAL LYS VAL LYS SER ASP ILE SEQRES 9 B 214 SER MET GLU GLU ASP SER PHE ILE TYR GLU ILE HIS LEU SEQRES 10 B 214 LYS GLY GLU ASN PHE PRO PRO ASN GLY PRO VAL MET GLN SEQRES 11 B 214 LYS LYS THR LEU LYS TRP GLU PRO SER THR GLU ILE LEU SEQRES 12 B 214 TYR VAL ARG ASP GLY VAL LEU VAL GLY ASP ILE LYS HIS SEQRES 13 B 214 LYS LEU LEU LEU GLU GLY GLY GLY HIS HIS ARG VAL ASP SEQRES 14 B 214 PHE LYS THR ILE TYR ARG ALA LYS LYS ALA VAL LYS LEU SEQRES 15 B 214 PRO ASP TYR HIS PHE VAL ASP HIS ARG ILE GLU ILE LEU SEQRES 16 B 214 ASN HIS ASP LYS ASP TYR ASN LYS VAL THR VAL TYR GLU SEQRES 17 B 214 SER ALA VAL ALA ARG TYR MODRES 2OTB PIA A 66 ALA MODRES 2OTB PIA A 66 TYR MODRES 2OTB PIA A 66 GLY MODRES 2OTB PIA B 66 ALA MODRES 2OTB PIA B 66 TYR MODRES 2OTB PIA B 66 GLY HET PIA A 66 20 HET PIA B 66 20 HETNAM PIA [(4Z)-2-[(1S)-1-AMINOETHYL]-4-(4-HYDROXYBENZYLIDENE)-5- HETNAM 2 PIA OXO-4,5-DIHYDRO-1H-IMIDAZOL-1-YL]ACETIC ACID FORMUL 1 PIA 2(C14 H15 N3 O4) FORMUL 3 HOH *410(H2 O) HELIX 1 1 TYR A 58 ASN A 63 1 6 HELIX 2 2 ASN A 81 SER A 86 1 6 HELIX 3 3 TYR B 58 ASN B 63 1 6 HELIX 4 4 TYR B 75 ILE B 79 5 5 HELIX 5 5 ASN B 81 SER B 86 1 6 SHEET 1 A13 THR A 140 TRP A 143 0 SHEET 2 A13 VAL A 156 LEU A 167 -1 O LEU A 166 N LEU A 141 SHEET 3 A13 HIS A 172 ALA A 183 -1 O TYR A 181 N LEU A 157 SHEET 4 A13 TYR A 91 PHE A 99 -1 N THR A 98 O ASP A 176 SHEET 5 A13 ILE A 104 GLU A 114 -1 O VAL A 107 N ARG A 95 SHEET 6 A13 SER A 117 GLU A 127 -1 O LYS A 125 N LYS A 106 SHEET 7 A13 MET A 12 VAL A 22 1 N LYS A 17 O ILE A 122 SHEET 8 A13 HIS A 25 LYS A 36 -1 O GLY A 33 N ILE A 14 SHEET 9 A13 THR A 41 GLU A 50 -1 O LYS A 49 N VAL A 28 SHEET 10 A13 LYS A 210 ARG A 220 -1 O VAL A 211 N LEU A 46 SHEET 11 A13 HIS A 193 HIS A 204 -1 N GLU A 200 O TYR A 214 SHEET 12 A13 SER A 146 ARG A 153 -1 N SER A 146 O HIS A 197 SHEET 13 A13 VAL A 156 LEU A 167 -1 O VAL A 158 N TYR A 151 SHEET 1 B13 THR B 140 TRP B 143 0 SHEET 2 B13 VAL B 156 LEU B 167 -1 O LEU B 166 N LEU B 141 SHEET 3 B13 HIS B 172 ALA B 183 -1 O TYR B 181 N LEU B 157 SHEET 4 B13 TYR B 91 PHE B 99 -1 N SER B 92 O ARG B 182 SHEET 5 B13 ILE B 104 GLU B 114 -1 O VAL B 107 N ARG B 95 SHEET 6 B13 SER B 117 GLU B 127 -1 O LYS B 125 N LYS B 106 SHEET 7 B13 MET B 12 VAL B 22 1 N ASN B 21 O GLY B 126 SHEET 8 B13 HIS B 25 LYS B 36 -1 O PHE B 27 N GLY B 20 SHEET 9 B13 THR B 41 GLU B 50 -1 O GLU B 47 N GLU B 30 SHEET 10 B13 LYS B 210 ARG B 220 -1 O VAL B 211 N LEU B 46 SHEET 11 B13 HIS B 193 HIS B 204 -1 N PHE B 194 O ARG B 220 SHEET 12 B13 SER B 146 ARG B 153 -1 N GLU B 148 O VAL B 195 SHEET 13 B13 VAL B 156 LEU B 167 -1 O VAL B 158 N TYR B 151 LINK C PHE A 65 N1 PIA A 66 1555 1555 1.33 LINK C3 PIA A 66 N ASN A 69 1555 1555 1.31 LINK C PHE B 65 N1 PIA B 66 1555 1555 1.33 LINK C3 PIA B 66 N ASN B 69 1555 1555 1.32 CISPEP 1 ALA A 52 PRO A 53 0 -1.31 CISPEP 2 PHE A 87 PRO A 88 0 5.38 CISPEP 3 ALA B 52 PRO B 53 0 -2.12 CISPEP 4 PHE B 87 PRO B 88 0 3.95 CRYST1 65.016 67.736 95.382 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015381 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014763 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010484 0.00000